| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |